Market Cap 53.46B
Revenue (ttm) 20.18B
Net Income (ttm) 1.71B
EPS (ttm) N/A
PE Ratio 13.18
Forward PE 12.72
Profit Margin 8.45%
Debt to Equity Ratio 0.69
Volume 1,540,300
Avg Vol 1,620,942
Day's Range N/A - N/A
Shares Out 286.63M
Stochastic %K 48%
Beta 0.25
Analysts Sell
Price Target $216.23

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-fre...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 847 6800
Website: www.bd.com
Address:
1 Becton Drive, Franklin Lakes, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 6:31 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BDX Current Share Price: $186.97 Contracts: $BDX December 18, 2026 $190 Calls Scale in: $17.18- $20.99 Scale out: $26.72-$34.35 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
seviay
seviay Oct. 24 at 1:42 AM
$BDX forward p/e under 14. Is this majorly slept on or what?
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 23 at 2:10 PM
$BDX RSI: 37.02, MACD: -0.0834 Vol: 2.94, MA20: 188.86, MA50: 189.84 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 5:03 AM
Enter: $BDX NOV 21 2025 $190 CALLS Buy in Price: $6.60 - $7.00 Take Profit: $13.30 Stop Bleeding: $6.16 ROI Potential: 90% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
prismmarketview
prismmarketview Oct. 22 at 3:04 PM
(NYSE: $BDX) BD introduces a new self-collection HPV test for markets outside the U.S., combining at-home convenience with robotic lab automation to boost cervical-cancer screening access and efficiency. https://prismmarketview.com/bd-launches-simplified-at-home-hpv-test-to-expand-global-cervical-cancer-screening/
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 22 at 11:54 AM
$BDX Share Price: $189.02 Contract Selected: Mar 20, 2026 $190 Calls Buy Zone: $11.09 – $13.70 Target Zone: $20.33 – $24.85 Potential Upside: 73% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 4:18 AM
Enter: $BDX NOV 21 2025 $190 CALLS Buy in Price: $5.90 - $6.70 Take Profit: $9.50 Stop Bleeding: $5.19 ROI Potential: 61% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 21 at 11:04 PM
$BDX Share Price: $189.02 Contract Selected: Mar 20, 2026 $190 Calls Buy Zone: $10.62 – $13.12 Target Zone: $19.72 – $24.10 Potential Upside: 75% ROI Time to Expiration: 149 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TalkMarkets
TalkMarkets Oct. 21 at 5:50 PM
3 Wealth-Building #Dividend Growth Stocks For The Long Run $ABT $BDX $GWW https://talkmarkets.com/content/stocks--equities/3-wealth-building-dividend-growth-stocks-for-the-long-run?post=529612
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 21 at 4:33 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BDX Current Share Price: $189.10 Contracts: $BDX December 18, 2026 $190 Calls Scale in: $17.18- $20.99 Scale out: $26.72-$34.35 Can Easily Capture: 60% ROI Blended DTE: 425 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Latest News on BDX
Becton Dickinson's CFO to depart

Oct 15, 2025, 4:42 PM EDT - 9 days ago

Becton Dickinson's CFO to depart


BD Announces CFO Transition Plan

Oct 15, 2025, 4:15 PM EDT - 9 days ago

BD Announces CFO Transition Plan


Best Dividend Aristocrats For October 2025

Sep 28, 2025, 1:00 AM EDT - 27 days ago

Best Dividend Aristocrats For October 2025

ABT ADP ATO BEN CAH CHRW CL


Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 2 months ago

Best Dividend Aristocrats For September 2025

ABBV ABT ADM ADP AFL ALB AMCR


Best Dividend Kings: August 2025

Aug 24, 2025, 10:13 PM EDT - 2 months ago

Best Dividend Kings: August 2025

ABBV ABM ABT ADM AWR BKH CINF


Becton, Dickinson: Great Time To Buy This Dividend Aristocrat

Aug 18, 2025, 8:00 AM EDT - 2 months ago

Becton, Dickinson: Great Time To Buy This Dividend Aristocrat


BD to Present at Wells Fargo 2025 Healthcare Conference

Aug 14, 2025, 4:15 PM EDT - 2 months ago

BD to Present at Wells Fargo 2025 Healthcare Conference


Becton Dickinson Q3 Beats Estimates On Medical Device Boom

Aug 7, 2025, 11:40 AM EDT - 2 months ago

Becton Dickinson Q3 Beats Estimates On Medical Device Boom


BD Reports Third Quarter Fiscal 2025 Financial Results

Aug 7, 2025, 6:30 AM EDT - 2 months ago

BD Reports Third Quarter Fiscal 2025 Financial Results


Best Dividend Aristocrats For August 2025

Jul 28, 2025, 5:19 AM EDT - 3 months ago

Best Dividend Aristocrats For August 2025

ABT BEN


22 Dividend Kings At Discounted Valuations

Jul 27, 2025, 12:14 PM EDT - 3 months ago

22 Dividend Kings At Discounted Valuations

ABM ADM AMZN AWR BKH CWT FRT


20 Kiplinger July Dividend Favorites: No Cigars

Jul 27, 2025, 11:45 AM EDT - 3 months ago

20 Kiplinger July Dividend Favorites: No Cigars

APD DUK EPD GS HD JNJ KVUE


BD Board Declares Dividend

Jul 22, 2025, 4:15 PM EDT - 3 months ago

BD Board Declares Dividend


Best Dividend Kings: July 2025

Jul 22, 2025, 9:31 AM EDT - 3 months ago

Best Dividend Kings: July 2025

ABBV ABM ABT ADM ADP AWR BKH


Best Dividend Aristocrats For July 2025

Jun 29, 2025, 7:19 AM EDT - 4 months ago

Best Dividend Aristocrats For July 2025

ABBV ABT ADM ADP AFL ALB AMCR


New vaccine panel meeting underway

Jun 26, 2025, 11:46 AM EDT - 4 months ago

New vaccine panel meeting underway

BMY MRK UNH ZBH


Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now

Jun 25, 2025, 8:33 AM EDT - 4 months ago

Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now


Best Dividend Kings: June 2025

Jun 24, 2025, 8:49 AM EDT - 4 months ago

Best Dividend Kings: June 2025

ABT ADM BKH ED EMR FTS FUL


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 6:31 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BDX Current Share Price: $186.97 Contracts: $BDX December 18, 2026 $190 Calls Scale in: $17.18- $20.99 Scale out: $26.72-$34.35 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
seviay
seviay Oct. 24 at 1:42 AM
$BDX forward p/e under 14. Is this majorly slept on or what?
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 23 at 2:10 PM
$BDX RSI: 37.02, MACD: -0.0834 Vol: 2.94, MA20: 188.86, MA50: 189.84 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 5:03 AM
Enter: $BDX NOV 21 2025 $190 CALLS Buy in Price: $6.60 - $7.00 Take Profit: $13.30 Stop Bleeding: $6.16 ROI Potential: 90% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
prismmarketview
prismmarketview Oct. 22 at 3:04 PM
(NYSE: $BDX) BD introduces a new self-collection HPV test for markets outside the U.S., combining at-home convenience with robotic lab automation to boost cervical-cancer screening access and efficiency. https://prismmarketview.com/bd-launches-simplified-at-home-hpv-test-to-expand-global-cervical-cancer-screening/
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 22 at 11:54 AM
$BDX Share Price: $189.02 Contract Selected: Mar 20, 2026 $190 Calls Buy Zone: $11.09 – $13.70 Target Zone: $20.33 – $24.85 Potential Upside: 73% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 4:18 AM
Enter: $BDX NOV 21 2025 $190 CALLS Buy in Price: $5.90 - $6.70 Take Profit: $9.50 Stop Bleeding: $5.19 ROI Potential: 61% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 21 at 11:04 PM
$BDX Share Price: $189.02 Contract Selected: Mar 20, 2026 $190 Calls Buy Zone: $10.62 – $13.12 Target Zone: $19.72 – $24.10 Potential Upside: 75% ROI Time to Expiration: 149 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TalkMarkets
TalkMarkets Oct. 21 at 5:50 PM
3 Wealth-Building #Dividend Growth Stocks For The Long Run $ABT $BDX $GWW https://talkmarkets.com/content/stocks--equities/3-wealth-building-dividend-growth-stocks-for-the-long-run?post=529612
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 21 at 4:33 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BDX Current Share Price: $189.10 Contracts: $BDX December 18, 2026 $190 Calls Scale in: $17.18- $20.99 Scale out: $26.72-$34.35 Can Easily Capture: 60% ROI Blended DTE: 425 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 2:35 AM
Enter: $BDX NOV 21 2025 $190 CALLS Buy in Price: $7.00 - $7.00 Take Profit: $15.96 Stop Bleeding: $6.16 ROI Potential: 128% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 1:33 AM
Enter: $BDX NOV 21 2025 $190 CALLS Buy in Price: $7.00 - $7.00 Take Profit: $16.80 Stop Bleeding: $6.16 ROI Potential: 140% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 18 at 7:37 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BDX Current Share Price: $185.27 Contracts: $BDX December 18, 2026 $190 Calls Scale in: $17.18- $20.99 Scale out: $26.72-$34.35 Can Easily Capture: 60% ROI Blended DTE: 427 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 18 at 6:02 AM
Enter: $BDX NOV 21 2025 $190 CALLS Buy in Price: $6.60 - $6.60 Take Profit: $14.26 Stop Bleeding: $5.81 ROI Potential: 116% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
JarvisFlow
JarvisFlow Oct. 16 at 2:02 PM
RBC Capital updates rating for Becton Dickinson ( $BDX ) to Sector Perform, target set at 211.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 1:46 PM
Enter: $BDX NOV 21 2025 $190 CALLS Buy in Price: $6.70 - $6.80 Take Profit: $15.75 Stop Bleeding: $5.90 ROI Potential: 135% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
Tokenist
Tokenist Oct. 16 at 1:37 PM
📉 $BDX under pressure. Shares slid in premarket after CFO Chris DelOrefice announced his exit, even as Becton Dickinson posted strong year-end results. 💰 Q4 revenue climbed 8.3% YoY to $5.9B, with full-year sales hitting $21.8B, but the surprise leadership change spooked investors. DelOrefice leaves Dec 5, with Vitor Roque, a 20-year BD veteran, stepping in as interim CFO. 🏥 The timing couldn’t be worse—U.S. regulators just launched a medical-device import probe, slamming medtech stocks across the board. That, plus the CFO shuffle, sent $BDX down ~6% after hours and another 1% premarket. 📊 Despite the selloff, analysts stay bullish with an average price target of $208—roughly 15% upside from current levels. But with leadership uncertainty and sector pressure, investors are treading carefully heading into the Nov 6 earnings call.
1 · Reply
OpenOutcrier
OpenOutcrier Oct. 16 at 12:54 PM
$BDX (-3.1% pre) Becton, Dickinson slips as FQ4, 2025 revenue estimates just below consensus https://ooc.bz/l/80786
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 16 at 12:35 PM
$BDX (-3.4% pre) Medical device maker Becton Dickinson's CFO to depart; shares slide https://ooc.bz/l/80739
0 · Reply
11thestate
11thestate Oct. 16 at 12:30 PM
$BDX is now accepting claims for an $85M settlement it is paying to investors over claims that it misled them about the functionality and safety of its Alaris infusion pumps. Even if you missed the deadline, if you bought $BDX between November 5, 2019, and February 5, 2020, you still can file for payment here: https://11th.com/cases/bdx-shareholder-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=10162025_1
0 · Reply
zztopps
zztopps Oct. 16 at 5:17 AM
$BDX More disappointment, down close to 20% YTD. What a big dog, and not in a good way. Where's the juice?
0 · Reply
DonCorleone77
DonCorleone77 Oct. 15 at 8:22 PM
$BDX Becton Dickinson CFO Chris DelOrefice to depart, Vitor Roque interim CFO -- Sees Q4 revenue ~$5.9B, consensus $5.91B -- Sees FY25 revenue ~$21.8B, consensus $21.86B -- Sees FY25 EPS 'at or above' midpoint of prior guidance
0 · Reply